Democrats want to keep Obamacare going. Republicans want to replace it, ideally with health savings accounts. Regardless of which approach holds sway this week—or whenever—either one would be woefully shortsighted. 

When the devices needed for a specific procedure were not available, a group of surgeons got creative. Their one-of-a-kind approach was a success, and the patient has experienced no complications.

A new report from the New York Times reveals a system of de facto quid pro quo where wealthy patients from oil-rich nations are sometimes moved to the top of organ transplant lists.

Physicians love AI scribes. Has anyone thought to ask patients what they think?

The Pennsylvania-based drug distributor announced it would be buying OneOncology, a physician-led specialty service group in which it already owned a minority stake. The company said the acquisition will complement its "pharmaceutical-centric strategy." 

The new guidance, published in JACC, focuses on three classes of commonly used anticancer therapies.

After an official request from Edwards Lifesciences, CMS is rethinking its coverage policy for the use of TAVR to treat asymptomatic severe aortic stenosis. The agency is accepting public comments on this topic until Jan. 14. 

Perhaps the biggest sticking point in the debate around remote imaging operations relates to the bedside. If a technologist is running the exam remotely, who is tending to patients on-site?